未登录

L

Lejiao Jia

Shandong University

H指数:24

被引数:2,169

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Targeted delivery of HSP90 inhibitors for efficient therapy of CD44-positive acute myeloid leukemia and solid tumor-colon cancer

JOURNAL OF NANOBIOTECHNOLOGY

IF12.6

2024-04-221

OAAI

Smart and Generalizable Cytarabine Derivative-Triggered Nanoparticles for Synergistic Therapy of Relapsed/Refractory Acute Myeloid Leukemia

智能和可推广的阿糖胞苷衍生物触发纳米粒协同治疗复发/难治性急性髓系白血病

ACS APPLIED MATERIALS & INTERFACES

IF8.2

2023-05-302

PRE

DT7 peptide-modified lecithin nanoparticles co-loaded with γ-secretase inhibitor and dexamethasone efficiently inhibit T-cell acute lymphoblastic leukemia and reduce gastrointestinal toxicity

IF10.1

2022-05-015

OA

A targeted and redox/pH-responsive chitosan oligosaccharide derivatives based nanohybrids for overcoming multidrug resistance of breast cancer cells

CARBOHYDRATE POLYMERS

IF12.5

2021-01-0138

PREAI

Multifunctional mesoporous silica nanoparticles mediated co-delivery of paclitaxel and tetrandrine for overcoming multidrug resistance

INTERNATIONAL JOURNAL OF PHARMACEUTICS

IF5.2

2015-07-0191

PREAI

Discovery of diamine-linked 17-aroylamido-17-demethoxygeldanamycins as potent Hsp90 inhibitors

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IF5.9

2014-11-0116

PREAI

Design, synthesis and biological evaluation of 17-arylmethylamine-17-demethoxygeldanamycin derivatives as potent Hsp90 inhibitors

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IF5.9

2014-10-0122

PREAI

Discovery of Novel 17-Phenylethylaminegeldanamycin Derivatives as Potent Hsp90 Inhibitors

CHEMICAL BIOLOGY & DRUG DESIGN

IF3.3

2014-06-2610

PREAI

Self-assembled nanoparticles based on galactosylated O-carboxymethyl chitosan-graft-stearic acid conjugates for delivery of doxorubicin

INTERNATIONAL JOURNAL OF PHARMACEUTICS

IF5.2

2013-12-0186

PREAI

Synthesis, characterization, in vitro and in vivo evaluation of PEGylated oridonin conjugates

INTERNATIONAL JOURNAL OF PHARMACEUTICS

IF5.2

2013-11-0129

PREAI

Nanosuspension for parenteral delivery of a p-terphenyl derivative: Preparation, characteristics and pharmacolcinetic studies

COLLOIDS AND SURFACES B-BIOINTERFACES

IF5.6

2013-08-0126

PREAI

In vitro and in vivo evaluation of paclitaxel-loaded mesoporous silica nanoparticles with three pore sizes

三种孔径的紫杉醇介孔二氧化硅纳米颗粒的体内外评价

INTERNATIONAL JOURNAL OF PHARMACEUTICS

IF5.2

2013-03-01105

PRE

In vitro and in vivo evaluation of riccardin D nanosuspensions with different particle size

COLLOIDS AND SURFACES B-BIOINTERFACES

IF5.6

2013-02-0149

PREAI

Successfully tailoring the pore size of mesoporous silica nanoparticles: Exploitation of delivery systems for poorly water-soluble drugs

INTERNATIONAL JOURNAL OF PHARMACEUTICS

IF5.2

2012-12-0184

PREAI

Galactosylated chitosan nanoparticles for hepatocyte-targeted delivery of oridonin

INTERNATIONAL JOURNAL OF PHARMACEUTICS

IF5.2

2012-10-0151

PREAI

In vivo studies on the oridonin-loaded nanostructured lipid carriers

IF8.1

2012-08-2813

OAAI

In vitro and in vivo evaluation of oridonin-loaded long circulating nanostructured lipid carriers

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES

IF8.5

2012-04-0170

PREAI

Comparison of different methods for preparation of a stable riccardin D formulation via nano-technology

INTERNATIONAL JOURNAL OF PHARMACEUTICS

IF5.2

2012-01-0136

PREAI

Studies on pharmacokinetics and tissue distribution of bifendate nanosuspensions for intravenous delivery

JOURNAL OF MICROENCAPSULATION

IF3.2

2011-12-1618

PREAI

Synergistic effect of folate-mediated targeting and verapamil-mediated P-gp inhibition with paclitaxel -polymer micelles to overcome multi-drug resistance

IF12.9

2011-12-01167

PREAI